<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1025-0255</journal-id>
<journal-title><![CDATA[Revista Archivo Médico de Camagüey]]></journal-title>
<abbrev-journal-title><![CDATA[AMC]]></abbrev-journal-title>
<issn>1025-0255</issn>
<publisher>
<publisher-name><![CDATA[Universidad de Ciencias Médicas de Camagüey]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1025-02552020000500006</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Brote por Parvovirus B19 asociado a la atención sanitaria en un hospital al norte del Perú]]></article-title>
<article-title xml:lang="en"><![CDATA[Parvovirus B19 outbreak associated with healthcare in a hospital in northern Peru]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Aguilar-Gamboa]]></surname>
<given-names><![CDATA[Franklin Rómulo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Becerra-Gutiérrez]]></surname>
<given-names><![CDATA[Lizzie Karen]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[León-Jiménez]]></surname>
<given-names><![CDATA[Franco Ernesto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Regional de Lambayeque Dirección de investigación Laboratorio de Inmunología y Virología]]></institution>
<addr-line><![CDATA[Lambayeque ]]></addr-line>
<country>Perú</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad de San Martin de Porres Facultad de Medicina. Laboratorio de Inmunología y Virología Hospital Regional Lambayeque]]></institution>
<addr-line><![CDATA[Chiclayo ]]></addr-line>
<country>Perú</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad Señor de Sipán Hospital Santa Rosa Piura ]]></institution>
<addr-line><![CDATA[Chiclayo ]]></addr-line>
<country>Peru</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>10</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>10</month>
<year>2020</year>
</pub-date>
<volume>24</volume>
<numero>5</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1025-02552020000500006&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1025-02552020000500006&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1025-02552020000500006&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Fundamento:  parvovirus humano B19 es el agente causal de la quinta enfermedad en los niños y de la poliartropatía y la eritroblastopenia aguda en los adultos.  Objetivo:  determinar los aspectos clínicos, epidemiológicos y analíticos de la infección por parvovirus B19 durante un brote nosocomial.  Métodos:  se realizó un estudio trasversal descriptivo en los servicios de Medicina y Pediatría en el Hospital Regional de Lambayeque durante los meses de noviembre y diciembre de 2017. Se realizó un estudio de serie de casos en base a las historias clínicas de pacientes y personal de salud, con resultado positivo a la infección por PVB1, mediante la técnica de ELISA. El universo estuvo constituido por 153 pacientes atendidos en los servicios de Medicina y Pediatría en el tiempo mencionado. De los cuales se seleccionó una muestra de 16 casos, cumpliendo los criterios mencionados.  Resultados:  se identificaron 16 pacientes positivos de los servicios de Medicina y Pediatría, con títulos de IgM contra parvovirus B19 superiores a 17 UI/mL, cuyas edades oscilaron entre los seis meses y 38 años. Entre ellos ocho y 16 pacientes presentaron comorbilidades de las cuales 3/8 correspondieron a enfermedades autoinmunes. Se evidenciaron contactos intrahospitalarios en ambos servicios. Se encontró una mayor morbilidad en el personal de salud femenino de mediana edad.  Conclusiones:  la infección por parvovirus B19 en el hospital u otro medio sanitario representa un riesgo para el personal de salud.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Background:  human parvovirus B19 is the causative agent of fifth disease in children and of polyarthropathy and acute erythroblastopenia in adults.  Objective:  to determine the clinical, epidemiological and analytical aspects of parvovirus B19 infection during a nosocomial outbreak.  Methods:  a descriptive cross-sectional study was carried out in the Medicine and Pediatrics services of the Regional Lambayeque Hospital during the months of November and December 2017. A study of a series of cases was carried out based on the patients and health personnel historical charts, with a positive result to the PVB1 infection, through the ELISA technique. The universe was constituted by 153 patients treated in the Medicine and Pediatrics services. Of which it was selected a sample of 16 cases, based on the criteria.  Results:  16 positive patients from the Medicine and Pediatrics departments were identified, with IgM titers against parvovirus B19 greater than 17 IU / mL, whose ages ranged from 6 months to 38 years. Among them 8/16 patients presented comorbidities of which 3/8 corresponded to autoimmune diseases. In-hospital contacts were evident in both services. Greater morbidity was found in middle-aged female health personnel.  Conclusions:  Parvovirus B19 infection in the hospital or other health environment represents a risk mainly for health personnel.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[BROTES DE ENFERMEDADES/prevención&amp;control]]></kwd>
<kwd lng="es"><![CDATA[INFECCIONES POR PARVOVIRIDAE/epidemiología]]></kwd>
<kwd lng="es"><![CDATA[INFECCIONES POR PARVOVIRIDAE/transmisión]]></kwd>
<kwd lng="es"><![CDATA[PARVOVIRUS B19 HUMANO]]></kwd>
<kwd lng="es"><![CDATA[PERSONAL DE SALUD]]></kwd>
<kwd lng="en"><![CDATA[DISEASE OUTBREAKS/prevention&amp;control]]></kwd>
<kwd lng="en"><![CDATA[PARVOVIRIDAE INFECTIONS/epidemiology]]></kwd>
<kwd lng="en"><![CDATA[PARVOVIRIDAE INFECTIONS/transmission]]></kwd>
<kwd lng="en"><![CDATA[PARVOVIRUS B19, HUMAN]]></kwd>
<kwd lng="en"><![CDATA[HEALTH PERSONNEL]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Morinet]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Aladjidi]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Pillet]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Parvovirus B19]]></article-title>
<source><![CDATA[EMC-Pediatría]]></source>
<year>2013</year>
<volume>48</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>1-7</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ganaie]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Qiu]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Recent advances in replication and infection of human parvovirus B19]]></article-title>
<source><![CDATA[Front Cell Infect Microbiol]]></source>
<year>2018</year>
<volume>8</volume>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sungkate]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Phongsamart]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Rungmaitree]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Lapphra]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Wittawatmongkol]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Pumsuwan]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Human parvovirus B19 nosocomial outbreak in healthcare personnel in a paediatric ward at a national tertiary referral centre in Thailand]]></article-title>
<source><![CDATA[J Hosp Infect]]></source>
<year>2017</year>
<volume>96</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>163-7</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mancebo]]></surname>
<given-names><![CDATA[HA]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estudio de un brote de infección por parvovirus B19 en un hospital de la Ciudad de México]]></article-title>
<source><![CDATA[Acta Pediatr Mex]]></source>
<year>2006</year>
<volume>27</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>66-72</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lara Medrano]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez Reséndez]]></surname>
<given-names><![CDATA[MF]]></given-names>
</name>
<name>
<surname><![CDATA[Garza González]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Medina Torres]]></surname>
<given-names><![CDATA[AG]]></given-names>
</name>
<name>
<surname><![CDATA[Camacho Ortiz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Outbreak of parvovirus B19 infection among anesthesiology and surgical fellows]]></article-title>
<source><![CDATA[Am J Infect Control]]></source>
<year>2016</year>
<volume>44</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1069-70</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sharif]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Aghakhani]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Velayati]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
<name>
<surname><![CDATA[Banifazl]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Sharif]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Razeghi]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Frequency and Genotype of Human Parvovirus B19 among Iranian Hemodialysis and Peritoneal Dialysis Patients]]></article-title>
<source><![CDATA[Intervirology]]></source>
<year>2017</year>
<volume>59</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>179-85</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Parra]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Mekki]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Durieu]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Broussolle]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Sève]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Manifestations cliniques et biologiques de la primo-infection à parvovirus B19 étude rétrospective de 26 observations Clinical and biological manifestations in primary parvovirus B19 infection in immunocompetent adult: A retrospective study of 26 cases]]></article-title>
<source><![CDATA[Rev Med Interne]]></source>
<year>2014</year>
<volume>35</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>289-96</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Berger]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Doerr]]></surname>
<given-names><![CDATA[HW]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Preventing vertical virus infections the role of serologic screening of pregnant women]]></article-title>
<source><![CDATA[Med Microbiol Immunol]]></source>
<year>2018</year>
<volume>207</volume>
<numero>5-6</numero>
<issue>5-6</issue>
<page-range>249-53</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Francois]]></surname>
<given-names><![CDATA[KL]]></given-names>
</name>
<name>
<surname><![CDATA[Parboosing]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Moodley]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Parvovirus B19 in South African blood donors]]></article-title>
<source><![CDATA[J Med Virol]]></source>
<year>2019</year>
<volume>91</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1217-23</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Staroselsky]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Klieger-Grossmann]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Garcia-Bournissen]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Koren]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Exposure to fifth disease in pregnancy]]></article-title>
<source><![CDATA[Can Fam Physician]]></source>
<year>2009</year>
<volume>55</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1195-8</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Oliveira]]></surname>
<given-names><![CDATA[MI de]]></given-names>
</name>
<name>
<surname><![CDATA[Afonso]]></surname>
<given-names><![CDATA[AMS]]></given-names>
</name>
<name>
<surname><![CDATA[Curti]]></surname>
<given-names><![CDATA[SP]]></given-names>
</name>
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[PE]]></given-names>
</name>
<name>
<surname><![CDATA[Barbosa]]></surname>
<given-names><![CDATA[TF]]></given-names>
</name>
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[JER]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Genotype 1 of human parvovirus B19 in clinical cases]]></article-title>
<source><![CDATA[Rev Assoc Med Bras]]></source>
<year>2017</year>
<volume>63</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>224-8</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Haston]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Rostad]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Jerris]]></surname>
<given-names><![CDATA[RC]]></given-names>
</name>
<name>
<surname><![CDATA[Milla]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[McCracken]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Pratt]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prospective Cohort Study of Next-Generation Sequencing as a Diagnostic Modality for Unexplained Encephalitis in Children]]></article-title>
<source><![CDATA[J Pediatric Infect Dis Soc]]></source>
<year>2020</year>
<volume>9</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>326-33</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jun]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Moon]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Byun]]></surname>
<given-names><![CDATA[JI]]></given-names>
</name>
<name>
<surname><![CDATA[Sunwoo]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Lim]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[ST]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical manifestations and treatment outcomes of parvovirus B19 encephalitis in immunocompetent adults]]></article-title>
<source><![CDATA[J Neurovirol]]></source>
<year>2017</year>
<volume>23</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>903-7</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Georges]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Rihova]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Cmejla]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Decleire]]></surname>
<given-names><![CDATA[PY]]></given-names>
</name>
<name>
<surname><![CDATA[Langen]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Parvovirus B19 induced lupus-like syndrome with nephritis]]></article-title>
<source><![CDATA[Acta Clin Belg]]></source>
<year>2016</year>
<volume>71</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>423-5</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="book">
<collab>Mayo Clinic</collab>
<source><![CDATA[Eritema infeccioso-Síntomas y causas]]></source>
<year>2020</year>
<publisher-loc><![CDATA[EU ]]></publisher-loc>
<publisher-name><![CDATA[Mayo Foundation for Medical Education and Research]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
